RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $291,000 | -74.0% | 22,306 | -60.9% | 0.00% | -66.7% |
| Q2 2021 | $1,118,000 | -82.2% | 57,078 | -80.6% | 0.00% | -81.2% |
| Q1 2021 | $6,267,000 | +790.2% | 294,660 | +1144.3% | 0.02% | +700.0% |
| Q4 2020 | $704,000 | +49.5% | 23,681 | +8.9% | 0.00% | 0.0% |
| Q3 2020 | $471,000 | -51.1% | 21,742 | -48.1% | 0.00% | -33.3% |
| Q4 2019 | $963,000 | +280.6% | 41,922 | +264.5% | 0.00% | +200.0% |
| Q2 2019 | $253,000 | -34.6% | 11,500 | -18.6% | 0.00% | 0.0% |
| Q1 2019 | $387,000 | – | 14,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |